BOAN BIOTECH (06955) Sets 30 March 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

Mar 17

Shandong Boan Biotechnology Co., Ltd. (BOAN BIOTECH, 06955) has notified shareholders that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:

• Approval and release of the audited financial results for the year ended 31 December 2025. • Deliberation on the declaration and amount of a potential final dividend for shareholders.

The notice, dated 17 March 2026 and signed by Chairlady, Chief Executive Officer and Executive Director Jiang Hua, confirms current board composition as follows:

• Executive Directors: Jiang Hua, Dou Changlin, Wang Shenghan. • Non-Executive Directors: Liu Yuanchong, Li Li, Li Shixu. • Independent Non-Executive Directors: Professor Shi Luwen, Dai Jixiong, Yu Jialin.

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim responsibility for the announcement’s contents.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1119869466"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119869466\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119869466?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 21:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119869466","market":"us","top_or_hot":-1,"title":"BOAN BIOTECH (06955) Sets 30 March 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","media":"Bulletin Express","content":"<p>Shandong Boan Biotechnology Co., Ltd. (BOAN BIOTECH, 06955) has notified shareholders that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:</p>\n<p>• Approval and release of the audited financial results for the year ended 31 December 2025.  \n• Deliberation on the declaration and amount of a potential final dividend for shareholders.</p>\n<p>The notice, dated 17 March 2026 and signed by Chairlady, Chief Executive Officer and Executive Director Jiang Hua, confirms current board composition as follows:</p>\n<p>• Executive Directors: Jiang Hua, Dou Changlin, Wang Shenghan.  \n• Non-Executive Directors: Liu Yuanchong, Li Li, Li Shixu.  \n• Independent Non-Executive Directors: Professor Shi Luwen, Dai Jixiong, Yu Jialin.</p>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim responsibility for the announcement’s contents.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BOAN BIOTECH (06955) Sets 30 March 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBOAN BIOTECH (06955) Sets 30 March 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-17 21:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Boan Biotechnology Co., Ltd. (BOAN BIOTECH, 06955) has notified shareholders that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:</p>\n<p>• Approval and release of the audited financial results for the year ended 31 December 2025.  \n• Deliberation on the declaration and amount of a potential final dividend for shareholders.</p>\n<p>The notice, dated 17 March 2026 and signed by Chairlady, Chief Executive Officer and Executive Director Jiang Hua, confirms current board composition as follows:</p>\n<p>• Executive Directors: Jiang Hua, Dou Changlin, Wang Shenghan.  \n• Non-Executive Directors: Liu Yuanchong, Li Li, Li Shixu.  \n• Independent Non-Executive Directors: Professor Shi Luwen, Dai Jixiong, Yu Jialin.</p>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim responsibility for the announcement’s contents.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06955","symbol_name":"博安生物","start_time":0,"source_url":"","article_id":"1119869466","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119869466","pubTimestamp":1773754860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Boan Biotechnology Co., Ltd. (BOAN BIOTECH, 06955) has notified shareholders that its board of directors will convene on 30 March 2026. The meeting’s agenda includes: • Approval and release...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06955":"博安生物"},"translate_title":"博安生物(06955)定于2026年3月30日召开董事会批准2025财年业绩并考虑末期股息","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06955":1},"content_text":"Shandong Boan Biotechnology Co., Ltd. (BOAN BIOTECH, 06955) has notified shareholders that its board of directors will convene on 30 March 2026. The meeting’s agenda includes:\n• Approval and release of the audited financial results for the year ended 31 December 2025.  \n• Deliberation on the declaration and amount of a potential final dividend for shareholders.\nThe notice, dated 17 March 2026 and signed by Chairlady, Chief Executive Officer and Executive Director Jiang Hua, confirms current board composition as follows:\n• Executive Directors: Jiang Hua, Dou Changlin, Wang Shenghan.  \n• Non-Executive Directors: Liu Yuanchong, Li Li, Li Shixu.  \n• Independent Non-Executive Directors: Professor Shi Luwen, Dai Jixiong, Yu Jialin.\nHong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim responsibility for the announcement’s contents.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}